升白冲剂治疗恶性肿瘤化疗后血细胞减少症的临床观察

周维顺; 谢长生; 吴良村; 沈敏鹤; 陈培丰

您当前的位置：

首页 >

文章列表页 >

升白冲剂治疗恶性肿瘤化疗后血细胞减少症的临床观察

更新时间：2024-01-04

- 升白冲剂治疗恶性肿瘤化疗后血细胞减少症的临床观察
- Clinical 0bservation on Effect of Shenbai Granule on Hypocytosis Induced by Chemotherapy in Cancer Patients
- 中国实验方剂学杂志 1997年3卷第2期页码：16-18
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R730.53
- 纸质出版日期：1997
- 稿件说明：
移动端阅览
周维顺, 谢长生, 吴良村, 等. 升白冲剂治疗恶性肿瘤化疗后血细胞减少症的临床观察[J]. 中国实验方剂学杂志, 1997,3(2):16-18.

Zhou Weishun, Xie Changsheng, Wu Liangcun, et al. Clinical 0bservation on Effect of Shenbai Granule on Hypocytosis Induced by Chemotherapy in Cancer Patients[J]. Chinese journal of experimental traditional medical formulae, 1997, 3(2): 16-18.
周维顺, 谢长生, 吴良村, 等. 升白冲剂治疗恶性肿瘤化疗后血细胞减少症的临床观察[J]. 中国实验方剂学杂志, 1997,3(2):16-18. DOI：

Zhou Weishun, Xie Changsheng, Wu Liangcun, et al. Clinical 0bservation on Effect of Shenbai Granule on Hypocytosis Induced by Chemotherapy in Cancer Patients[J]. Chinese journal of experimental traditional medical formulae, 1997, 3(2): 16-18. DOI：

摘要

用升白冲剂(治疗组)与升白细胞西药(对照组)治疗恶性肿瘤化疗后血细胞减少症238例

结果：治疗组升高血细胞总有效率明显高于对照组

P＜0.01

且治疗组还能减轻化疗病人的毒副作用。

Abstract

The effect of Shenbai granule(SBG) and the Western medicine on the hypocytosis caused by chemotherapy were studied in 238 cancer patients.They were divided into A and B groups at random.It Was shown that the effect of group A(SBG) was obviously superi or to that of group B(Western Medicine)in protection of bone marrow

Furthermore

SBG could relief the other toxic or side effects induced by chemotherapy in cancer patients.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

康艾注射液配合化疗对恶性肿瘤患者生活质量及免疫功能的影响

基于代谢重编程探讨中药干预恶性肿瘤转移的研究进展

小柴胡汤在恶性肿瘤全程管理中的应用研究进展

恶性肿瘤“五期演变”规律的生物学基础

五观辨治-构建中医药防治肿瘤新体系